Objective: To determine the correlation between insulin sensitivity (S I ) obtained by the minimal model method applied to a frequently sampled n 33 intravenous glucose tolerance test (FSIGT 33 ), and values obtained by reduced FSIGTs, oral glucose tolerance test (OGTT), or fasting. Design: Retrospective analysis on tests performed in prospective studies. Methods: A total of 78 FSIGT 33 , and 59 OGTT were performed in non-diabetic women of which 10 were young cyclic females in the early follicular menstrual phase, 10 were young non-obese subjects with polycystic ovary syndrome (PCOS) and 30 were in post-menopause. Some of these individuals were investigated both prior to and during speci®ed treatments. FSIGT 33 was transformed into FSIGT 22 and FSIGT 12 by removing samples from the analysis. Values of S I derived from reduced FSIGTs or calculations performed on glucose and insulin values observed in fasting conditions and/or during OGTT were related to those of FSIGT 33 . Results: S I values derived from FSIGT 33 were highly correlated with those derived from FSIGT 22 r 0X965 or FSIGT 12 r 0X955Y but were only weakly correlated with those derived from fasting or OGTT calculations (r below 0.5). Between-group (PCOS vs normal) or within-group (prior to and during treatment) comparisons showed that reduced FSIGTs were only slightly less powerful than FSIGT 33 in detecting differences in S I . Conclusions: In non-diabetic women, reduced FSIGTs but not calculations based on fasting or OGTT values may be used in place of FSIGT 33 to document S I and its variation.
Introduction
Determination of insulin resistance is becoming critical in clinical practice. Insulin resistance represents a pathogenic mechanism for the polycystic ovary syndrome (PCOS) (1) , and an important risk factor for cardiovascular diseases (2, 3) . In 1997, the Consensus Development Conference on Insulin Resistance of the American Diabetes Association (4) established that only two methods can accurately estimate peripheral resistance to insulin, i.e. the euglycemic insulin clamp and the minimal model method applied to a frequently sampled intravenous glucose tolerance test (FSIGT). Both methods are cumbersome and not applicable either to large clinical trials or to the daily clinical investigation. Accordingly, several authors have proposed analyses of insulin sensitivity (S I ) based on reduced FSIGT procedures (5±7), or on mathematical calculations applied to fasting glucose and insulin values including the fasting glucose/insulin ratio (8± 10), the fasting insulin resistance index (FIRI) (11±13), the homeostasis model assessment of insulin resistance (HOMA-IR) (14±16), the sensitivity index (Sib) (17) and the quantitative insulin sensitivity check index (QUICKI) (18) . Other indices based on oral glucose tolerance test (OGTT) values have also been proposed, i.e. the sensitivity index at 2 h of OGTT (Si2h) (17) , the Sim (Sib+Si2h/2) (17), the ratio of the areas under the curves of glucose/insulin during the OGTT (19) , or the product of the two areas (19) . Furthermore, Cederholm and Wibell (20) , Bel®ore et al. (21) and Matsuda and DeFronzo (22) have recently proposed more complex calculations on fasting and OGTTderived insulin and glucose values. The aim of the present study was twofold: (i) to evaluate the relationship among values of S I obtained with the original FSIGT procedure, modi®ed with the i.v. administration of insulin (23, 24) and those obtained either with reduced FSIGTs or with calculations performed on fasting and/or OGTT values; (ii) in the case of strict relationship, to compare both in cross-sectional and longitudinal studies the capability of the alternative method vs the original FSIGT in detecting differences in S I .
Materials and methods

Subjects
Seventy-eight FSIGTs were performed in 50 nondiabetic women aged between 17 and 63 years (mean age 43.9^2.7 years), with a body mass index (BMI) between 20 and 29 (23.3^0.7) ( Table 1) . Most of these FSIGTs were performed during speci®c protocols and part of these results have already been published (25± 27). All procedures were previously approved by the local ethical committee on human experimentation and performed in accordance with the Helsinki declaration as revised in 1983. A written informed consent was obtained from each woman at enrolment. Ten women were young normal cyclic individuals, 10 were non-obese women suffering from polycystic ovary syndrome (PCOS), and 30 were postmenopausal women. PCOS was de®ned as persistent amenorrhea or oligomenorrhea of perimenarchal onset, with three or more of these features: the ratio of luteinizing hormone/follicle stimulating hormone .1.5, ovarian hyperandrogenism as de®ned by high levels of total testosterone, free testosterone or androstenedione, Ferriman Gallwey hirsutism score .10, ultrasound evidence of PCOS (25) . None of the subjects was suffering from non insulin-dependent diabetes mellitus (NIDDM) or IDDM, nor was on medications known to in¯uence glucose metabolism. As part of ongoing clinical trials in our laboratory, in most of the subjects FSIGTs were repeated twice, prior to and during a particular treatment. Gonadotropin-releasing hormone (GnRH) analogs (3.6 mg Zoladex; Zeneca, Milan, Italy) were administered for 3 months to young individuals with n 8 and without n 7 PCOS, while tibolone (Organon Italia, SpA, Rome, Italy; 2.5 mg/day; n 13 was administered for 3 months to women in postmenopause. Results of these trials and their rationale have already been published (25, 26) . In 59 cases, an OGTT had also been performed in the 7 days preceding FSIGT.
Methods
Frequently sampled intravenous glucose tolerance test Two polyethylene catheters placed in two antecubital veins were kept patent by a slow infusion of saline solution. One catheter was used for intravenous glucose or insulin administration and the other for blood collection. Glucose (0.3 g/kg) was injected over 1 min intravenously and was followed 20 min later by an i.v. insulin bolus (0.03 U/kg). As reported by Welch et al. (24) Processing of samples Blood samples were collected into heparinized glass tubes, placed on ice, and immediately centrifuged in a refrigerated centrifuge.
Glucose and insulin were measured in all samples. Serum glucose was immediately assayed by an autoanalyzer using the glucose oxidase method. Another aliquot of serum was immediately frozen at 225 8C until assayed. Insulin levels were assayed in duplicate by a radioimmunometric method using a commercially available kit (Biodata, Guidonia Montecelio, Rome, Italy) (25) , with intra-and interassay coef®cients of variation of 6.2% and 7% respectively, and a sensitivity of 14.35 pmol/l.
All the results are expressed as the mean^standard error.
Calculations
Comparisons of different FSIGT tests Glucose and insulin values obtained during the FSIGTs were used to calculate S I , which is inversely related to insulin resistance, and fractional glucose utilization independent on insulin (S G ) (23, 24) . Analyses were performed by the minimal model method, using a computerized algorithm (MINMOD) (23, 24) . S I was expressed in unitsÂ10 24 /minÂmU/ml, and S G in unitsÂ10 24 /min. Furthermore, AIRg (incremental insulin above baseline at the different time points between 2 and 10 min of FSIGT/number of time points considered), the disposition index AIRg Â S I Y basal insulin effectiveness (BIE; S I Âfasting insulin), and glucose effectiveness at zero insulin (GEZI; S G 2BIE) were also calculated (28) .
The same calculations performed on the FSIGT 33 were repeated by progressively removing some time points, and thus obtaining the FSIGT 22 33 by linear regression analysis. Furthermore, the capability of FSIGT 22 and FSIGT 12 to detect differences in S I and S G among different groups of subjects (by Student's t-test) or in the same group of subjects prior to and during a treatment (by t-test for paired data) was also tested. Analysis of variance (ANOVA) was also used as speci®ed, and when signi®cant was followed by the post-hoc test of Scheffe Â.
Comparison of FSIGT with fasting calculations
Calculations of S I obtained by considering fasting levels of glucose and insulin, as obtained during the FSIGT 33 procedure, were regressed on S I values obtained with FSIGT 33 . The following calculations were tested: fasting glucose/fasting insulin (G/I) (8±10); FIRI: fasting values of glucoseÂinsulin/25 (11±13); HOMA-IR: fasting values of glucoseÂinsulin/22.5 (14±16); Sib: 10 8 /fasting glucoseÂfasting insulinÂ150Âkg (17); QUICKI: 1/(log fasting glucose+log fasting insulin) (18) . (21); Composite evaluation: 10 000/square root of (mean glucose of OGTTÂmean insulin of OGTT)Â(fasting glucoseÂ fasting insulin) (22) .
Results
The clinical data of the three subsets of subjects in which investigations were performed are shown in Table 1 .
FSIGT 33 vs FSIGT 22 and FSIGT 12
Modeling of the results was not possible with both FSIGT 22 and FSIGT 12 in 3 out of the 78 investigations (3.8%) in which modeling was possible with FSIGT 33 . Linear regression analysis furnished a strong relationship between S I obtained from FSIGT 33 and that from FSIGT 22 r 0X965; P 0X0001 or FSIGT 12 r 0X955; P 0X0001 (Fig. 1) . A lower relationship was observed for S G values obtained from FSIGT 33 and those from FSIGT 22 r 0X754; P 0X0001 or FSIGT 12 r 0X726; P 0X0001 (Fig. 1) . Strong relationships, all close to unity and with r values higher than 0.94, were observed for AIRg, glucose disposition index and BIE from FSIGT 33 and the respective indices from FSIGT 22 and FSIGT 12 . GEZI from FSIGT 33 showed a lower relationship than the other indices to GEZI from FSIGT 22 r 0X815; P 0X0001 or FSIGT 12 r 0X811; P 0X0001X Application to cross-sectional studies Overall S I and S G values obtained from FSIGT 33 were similar to those obtained from FSIGT 22 or FSIGT 12 (Fig. 2) (Fig. 2) . The difference in S I between young non-obese women with and without PCOS detected with FSIGT 33 P 0X026 was reduced but still signi®cant when the same data were analyzed with FSIGT 22 P 0X039 and FSIGT 12 P 0X048X S G obtained with FSIGT 12 was similar to that obtained with FSIGT 33 in both young normal (0.260
.004 vs 0.03^0.003; +7.9%) and postmenopausal (0.031^0.004 vs 0.03^0.003; +9.2%) women, but was signi®cantly higher in women with PCOS (0.026^0.003 vs 0.029^0.004; +32.3%; P , 0X05 (Fig. 2) .
Application to prospective studies By using FSIGT 33 , we documented, as previously reported (26) , that in postmenopausal women n 13 the administration of tibolone for 2 months enhances S I (5.34^0.485 vs 8.44^1.4; P 0X04X This conclusion was con®rmed also with FSIGT 22 
Comparison of FSIGT with fasting calculations
S I values obtained with FSIGT 33 were weakly related to S I values obtained by fasting values of glucose or insulin and the derived calculations. Among all, the best correlation was found with Sib. However, the coef®cient of correlation between Sib and S I derived from FSIGT 33 was only 0.324 (Table 2 ). 33 . Calculations were performed considering all the women together (Tot) or the different subsets of young regularly cyclic women (young), postmenopausal women (Menop), and young lean women with polycystic ovary syndrome (PCOS). *P , 0X05Y **P , 0X025 vs the other two subsets (by ANOVA). Table 3) .
Comparisons of FSIGT with fasting or OGTTderived calculations in more insulin resistant subjects Correlations of S I derived from FSIGT 33 with those derived from FSIGT 22 or FSIGT 12 were virtually unchanged in individuals whose S I was below 4 n 42X On the other hand, a better but still low correlation was observed with S I derived from HOMA/ FIRI r 0X363Y Sib r 0X367 or QUICKI r 0X34X In this subset of more insulin resistant individuals, S I derived from FSIGT 33 was also better correlated with calculations performed on OGTT as G/I OGTT r 0X41Y Si2h r 0X25Y Sim r 0X59Y the Cederholm's index r 0X59Y the Bel®ore's index r 0X43Y or the Composite evaluation r 0X25X Also, in this subset Sim and the Cederholm's calculations were the two which were more closely related to values of S I derived from FSIGT 33 .
Discussion
In this study, we considered S I obtained by the minimal model method associated with FSIGT 33 as the reference value towards which to compare S I obtained by other methods or calculations. All the methods used to evaluate S I are based on assumptions that may reduce their accuracy. Some clinicians consider that the`gold standard' to evaluate S I is the clamp. This method is highly reproducible and capable of furnishing accurate data on glucose metabolism by the liver when associated with isotopes. On the other hand, it is very cumbersome, and requires multiple investigations at different insulin levels in order to assess the full spectrum of S I (4). In spite of its reputation, the clamp does not distinguish between insulin-dependent and -independent glucose utilization, and investigates the effect of insulin in a steady state, which is reached very slowly. This is different from the physiological dynamic of insulin which is secreted in acute bursts, followed by quick declines dependent upon insulin clearance. How well the steady state insulin predicts the effect of insulin in a dynamic situation is presently unknown. The minimal model method evaluates the effect of insulin in a dynamic situation. It is easier to perform and, in contrast to the clamp, allows the separate determination of insulin-dependent and insulinindependent glucose utilization (30) . The drawbacks of this method are that it does not distinguish between hepatic and peripheral glucose utilization, and that it is based on the assumption that liver extraction of insulin is constant throughout the test. Furthermore, it has been suggested that physiological oversimpli®cation by the model leads to errors in estimation of S G (31, 32) , although very likely not of S I (33, 34) . In spite of the differences between the minimal model method and the clamp, values of S I obtained by the two methods are strongly related (correlation coef®cient of r 0X89 (23) , and are likely predictive of true S I (4). In order to reduce complexity (blood sampling at 1-min intervals) and costs, minimal modeling of intravenous glucose tolerance tests with less frequent sampling have been proposed and used (5±7, 30, 32, 35) . In terms of S I , reduction in sampling frequency has already proved satisfactory for the original and the tolbutamide-modi®ed FSIGTs (36, 37) . Herein, we show that the same is true for the insulin-modi®ed FSIGT. S I values derived from insulin-modi®ed reduced FSIGTs are not only related among each other, as previously reported (5), but are also strongly related to FSIGT 33 . The strict correlation is re¯ected in the capability of reduced FSIGTs to document S I differences in cross-sectional and prospective clinical trials. Indeed, in both between and within groups' comparisons, reduced FSIGTs were only slightly less powerful than FSIGT 33 in detecting S I differences. Accordingly, it can be suggested that reduced FSIGTs, in particular FSIGT 12 , may replace FSIGT 33 in most clinical settings. FSIGT 12 is easier to perform because it eliminates samplings at 1-min intervals, requires fewer tubes to handle, and its cost is almost one third that of FSIGT 33 . 33 .
Oral glucose tolerance test is commonly used to evaluate glucose tolerance, and the possibility to obtain a contemporaneous estimate of S I is appealing. In the present study, S I estimations derived from mathematical calculations applied to values of OGTT were poorly correlated with those obtained from FSIGT 33 . S I values derived from Sim (17) or Cederholm (20, 29) calculations were the most related, but the correlation coef®cients remained below 0.5 for both of them.
In comparison to the correlation performed among different FSIGTs and fasting, the correlations performed among FSIGT 33 and OGTT-derived S I values were performed in a smaller but still signi®cant number of tests n 59Y suf®cient to document clear correlations among different S I values in previously published studies (5, 6, 10±12, 14, 17, 23, 24) . In addition, because they necessarily include between-tests and between-days variations, a lower correlation has to be expected. Nevertheless, the very low coef®cients of correlation detected may have several additional explanations. All S I indices derived from OGTT are based on assumptions that although correct bring a mathematical approximation capable of substantially in¯uencing S I results. Among these assumptions are that in the post-absorptive state, glucose uptake occurs only in insulin-dependent tissues (22) , that endogenous glucose production is equal to hepatic glucose production (22) , and that hepatic insulin sensitivity is equivalent to peripheral tissue insulin sensitivity (14± 16). Most importantly, the route of glucose administration is likely to play a major role. In contrast to the intravenous, the oral administration of glucose activates gastrointestinal factors that may induce marked modi®cations in insulin secretion and peripheral glucose utilisation (25, 27, 38) . Accordingly, OGTTderived S I values are frequently not interchangeable with those obtained by intravenous glucose administration, and unfortunately cannot be used in their place to document S I . Reported correlation among S I values from OGTT or fasting and the clamp are not con®rmed by the present data with the minimal model method. Unless it is ascertained that the minimal model method estimation of S I is completely wrong, we feel that present results do not substantiate the clinical use of OGTT or fasting calculations to assess S I .
In the subset of more insulin resistant individuals, a greater correlation r 0X59 was observed between values of S I derived from FSIGT 33 and those derived from OGTT, particularly for Sim and the Cederholm's calculation. An alternative index should be related to the method of reference across a wide range of S I values. However, it is possible that in states of severe insulin resistance a better correlation can be de®ned between S I derived from calculations on fasting or OGTT values and those derived from the minimal model method. Indeed, diabetic and frankly obese women were not included in the present study, and our results cannot be applied to this subset of individuals.
